Spine surgeon Vijay Yanamadala MD, completed Hartford, Conn.-based St. Vincent’s Ayer Neuroscience Institute’s first case with Royal Biologics’ Fibrinet biologic, the company said in an August. 12 LinkedIn post.
Fibrinet uses a patient’s own autologous blood to create a platelet-rich fibrin matrix/membrane, which can help facilitate spinal fusion.
Royal Biologics acquired the system from Vertical Spine in 2020.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
